SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-094733
Filing Date
2024-04-12
Accepted
2024-04-12 16:22:38
Documents
13
Period of Report
2024-04-11
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d827658d8k.htm   iXBRL 8-K 25980
  Complete submission text file 0001193125-24-094733.txt   148575

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20240411.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20240411_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20240411_pre.xml EX-101.PRE 11256
17 EXTRACTED XBRL INSTANCE DOCUMENT d827658d8k_htm.xml XML 3664
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 24841781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)